- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Merus Labs International Inc
+ Add to WatchlistMSLI:US
0.8258 USD 0.0223 2.78%As of 14:45:48 ET on 06/19/2013.
Snapshot for Merus Labs International Inc (MSLI)
| Open: | 0.8200 | Day's Range: | 0.8042 - 0.8322 | Volume: | 2,500 |
|---|---|---|---|---|---|
| Previous Close: | 0.8035 | 52wk Range: | 0.4619 - 1.9800 | 1-Yr Rtn: | -50.55% |
Key Statistics for MSLI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(09/2012) | 21.0006 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (CAD) (ttm) | - |
| Est. EPS (CAD) (09/2012) | 0.0400 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 14,216 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MSLI
No data available
Company Profile & Key Executives for MSLI
Merus Labs International, Inc. is a pharmaceutical company. The Company acquires and licenses niche branded pharmaceutical products in the United States and Canada. Merus's products include anti-infectives and wound care products.
| Ahmad DoroudianChief Executive Officer | Elie K FarahPresident/CEO |
| Andrew P PatientChief Financial Officer | Moira OngVP:Finance/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MSLI News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page